He has been trained in haematology at West midlands regional rotation at the Queen Elizabeth Hospital, Birmingham Heartlands Hospital, Birmingham Childrens Hospital, Birmingham City Hospital, Universty Hospital Coventry & Warwick in from April 1995 till 2001.
He has wide experience working with Haematology Malignancy Diagnostic Service (HMDS) Leeds and working along with Prof Peter Hillmen’s team at Leeds & Mid Yorkshire NHS Trust in 2001 , hence special interest in CLL and PNH treatments. Introduced pioneering treatment in High risk CLL in Worcestershire in conjunction with Leeds Clinical trials. Frontline Campath treatment in West Midlands was initiated at Worcestershire as per under the guidance from Prof Andrew Pettit from Liverpool. One of the earliest sites in West Midlands to implement Subcutaneous Campath at Worcestershire NHS trust.
Early experience in treating Paroxysmal Nocturnal Haemoglobinuria (PNH) with Eculizumab through Prof Peter Hillmen’s team locally in Worcestershire.
Earliest experience in treating relapsed Myeloma with Velcade before NICE approval in Worcestershire and has been the forerunner in getting approval for the drug locally through our Area prescribing committee in Worcestershire and benefited many patients in the county.
Wide experience in working as Consultant in different regions like North Manchester affiliated to Manchester Christie’s Haemato- Oncology Unit & Scottish experience working at Borders affiliated to Western General Hospital in Edinburgh.
Close relation with the Clinical Haematology unit in University Hospital Birmingham(UHB) under the guidance of Prof Charles Craddock in supporting all the Phase I & II clinical trials in AML , MDS and Myeloma. Active member of the regional research network closely linking with UHB through our Cure Leukaemia Trial nurses from Worcestershire. Also support the regional CML trials with Imatinib levels. Member of the Regional Trials group in Myeloma, Lymphoma, MDS & AML in West Midlands. Actively involved in setting up Regional integrated diagnostic Laboratory similar to HMDS Laboratory in Leeds along with Prof Charles Craddock. Since being the Clinical Director at Worcestershire has made strong links with Tertiary Centres in Birmingham
His areas of clinical interests are care of patients with leukaemia, myeloma and lymphoma and those worked towards Autologous and Allogenic Transplantation , which are done through Tertiary Centres like Queen Elizabeth Hospitals and Heatlands Hospital in Birmingham. He has a great passion for providing an excellent and prompt clinical service.
Honanary Senior Lecturer in Haematology at University of Birmingham since 2007 and involved in teaching and training both Undergraduates and Postgraduates at University of Birmingham.
As the Honorary Senior Lecturer of University of Birmingham ( Cancer studies) in association with Prof Paul Moss & Prof Charles Craddock has actively involved in teaching both Undergraduate Medical students and Postgraduate Medical students. Lead for year 3 Medical students teaching in Worcestershire in Haemato-Oncology. Actively involved in FRCPath teaching through the COMPLETE FRCPath course conducted by UHB under the leadership of Prof Charles Craddock at University Hospitals NHS Foundation trust.
As the main Principle Investigator for all National Clinical trials in Worcestershire is proud to be part of the second biggest NCRN clinical trials recruitment centre in West Midlands after Birmingham Heartlands Hospital. Our Trial recruitment has been significant in spite of 4 complex cancer network in Worcestershire. Personally setup a full team with 3 Trial nurses and Data clerk with CLRN funding. Worcestershire has been put in the Myeloma IX publications in 2011 as one of the major contributors. |
